Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +12.45% | +6.25% | +99.61% |
06:00am | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
May. 24 | YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 | MT |
Sales 2024 * | 596M 82.28M | Sales 2025 * | 827M 114M | Capitalization | 1.39B 192M |
---|---|---|---|---|---|
Net income 2024 * | -297M -40.99M | Net income 2025 * | -122M -16.84M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
-2.32
x | P/E ratio 2025 * |
-6.78
x | Employees | 773 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 18.57% |
1 day | +12.45% | ||
1 week | +6.25% | ||
Current month | +44.89% | ||
1 month | +27.50% | ||
3 months | +155.06% | ||
6 months | +58.14% | ||
Current year | +99.61% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Chun Yuan Wu
DFI | Director of Finance/CFO | 46 | 20-12-30 |
Zenaida Mojares
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Viren Mehta
BRD | Director/Board Member | 74 | - |
Hui Shao
CEO | Chief Executive Officer | 55 | 20-12-30 |
Ajit Shetty
CHM | Chairman | 77 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.02 | +12.45% | 107,250 |
24-05-23 | 0.9071 | -1.28% | 32,797 |
24-05-22 | 0.9189 | -6.23% | 37,682 |
24-05-21 | 0.98 | +2.08% | 64,000 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.61% | 192M | |
-1.64% | 90.28B | |
-0.66% | 39.5B | |
-15.83% | 31.71B | |
+62.42% | 26.41B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-10.32% | 11.8B | |
-45.77% | 10.95B | |
+3.45% | 8.85B |
- Stock Market
- Equities
- YS Stock